Cigna(US:CI)2026-02-05 11:15Financial Performance - Total revenues for 2025 increased 11% to $274.9 billion compared to $247.1 billion in 2024[6] - Shareholders' net income for 2025 was $6.0 billion, or $22.18 per share, up from $3.4 billion, or $12.12 per share in 2024[4] - Adjusted income from operations for 2025 was $8.0 billion, or $29.84 per share, compared to $7.7 billion, or $27.33 per share in 2024[5] - Total revenues for the year ended December 31, 2025, reached $274,900 million, up from $247,121 million in 2024, marking an increase of 11.3%[39] - Shareholders' net income for Q4 2025 was $1,234 million, a decrease of 13.3% compared to $1,424 million in Q4 2024[40] - Adjusted income from operations for the year ended December 31, 2025, was $8,014 million, compared to $7,741 million in 2024, reflecting a growth of 3.5%[40] - The diluted earnings per share for the year ended December 31, 2025, was $22.18, up from $12.12 in 2024, indicating a significant increase of 83.9%[41] Customer Growth - Total customer relationships increased 3% to 188.4 million as of December 31, 2025, from 182.2 million in 2024[10] - Total pharmacy customers increased 4% to 123.6 million as of December 31, 2025, driven by new sales and expansion[10] - Total medical customers are projected to be approximately 18.1 million[25] Future Projections - 2026 adjusted income from operations is projected to be at least $7.950 billion, or at least $30.25 per share[6] - The Cigna Group projects full year 2026 adjusted revenues to be approximately $280.0 billion[24] - The consolidated adjusted income from operations for 2026 is expected to be at least $7.950 billion, equating to at least $30.25 per share[25] - The adjusted SG&A expense ratio is projected to be around 5.0% for 2026[25] - The adjusted effective tax rate is anticipated to be approximately 19.0%[25] - Cash flow from operations is expected to be around $9.0 billion for 2026[25] - Capital expenditures are projected to be approximately $1.3 billion[25] - Shareholder dividends for 2026 are expected to be around $1.6 billion[25] - Cigna Healthcare's adjusted income from operations is expected to be at least $4.5 billion for 2026[25] - Evernorth's adjusted income from operations is projected to be at least $6.9 billion for 2026[25] Operational Performance - Adjusted revenues for Evernorth Health Services increased 17% in Q4 2025 compared to Q4 2024, with adjusted income from operations increasing 2%[16] - Cigna Healthcare adjusted revenues decreased 16% in Q4 2025 compared to Q4 2024, primarily due to the impact of the HCSC transaction[19] - Pharmacy revenues increased to $58,336 million in Q4 2025 from $49,941 million in Q4 2024, representing a growth of 16.0%[39] - Adjusted revenues for Q4 2025 were $72,495 million, up from $65,683 million in Q4 2024, representing a growth of 12.8%[39] - Evernorth Health Services reported pre-tax adjusted income of $2,188 million in Q4 2025, slightly up from $2,146 million in Q4 2024[39] - Cigna Healthcare's pre-tax adjusted income increased to $734 million in Q4 2025 from $511 million in Q4 2024, a growth of 43.7%[39] Shareholder Information - The Board of Directors declared an increase in the quarterly dividend to $1.56 per share, up from $1.51 per share in 2025[6] - The company's shareholders' equity at December 31, 2025, was $41,713 million, compared to $41,033 million at the end of 2024, an increase of 1.7%[39] - The debt-to-capitalization ratio was 43.0% at December 31, 2025, down from 44.9% at September 30, 2025[8] - The weighted average shares outstanding decreased to 265,699 thousand in Q4 2025 from 277,784 thousand in Q4 2024, a decline of 4.3%[39]